Related Experiment Video

Updated: Jul 1, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase

Irina U Agoulnik1, William E Bingman, Manjula Nakka

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.

Molecular Endocrinology (Baltimore, Md.)
|September 13, 2008
PubMed

Insights

Inhibiting p42/p44 MAPK reduces androgen receptor (AR) activity in prostate cancer. This approach offers potential for blocking AR expression and function, even in resistant tumors.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Androgen receptor (AR) signaling is crucial in prostate cancer, persisting even after androgen deprivation therapy.
  • AR is a phosphoprotein and its activity is linked to cell signaling pathways.
  • Targeting AR remains a key strategy for treating advanced prostate cancer.

Purpose of the Study:

  • To investigate if inhibiting specific cell signaling pathways can reduce androgen receptor (AR) function.
  • To explore the impact of p42/p44 MAPK inhibition on AR activity and gene expression.
  • To determine the effects of long-term p42/p44 MAPK inhibition on prostate cancer cells.

Main Methods:

  • Utilized a MAPK kinase inhibitor (U0126) and small interfering RNA to inhibit p42/p44 MAPK.
  • Assessed AR activity through target gene expression analysis (PSA, TMPRSS2, PMEPA1).
  • Examined histone H3 acetylation at AR target genes.
  • Investigated effects of long-term U0126 treatment on cell cycle and AR expression (mRNA and protein).

Main Results:

  • Short-term inhibition of p42/p44 MAPK selectively reduced AR activity at specific target genes.
  • AR-mediated histone H3 acetylation was gene-specific and sensitive to U0126.
  • Long-term U0126 treatment induced G1 cell cycle arrest.
  • Long-term U0126 treatment decreased AR mRNA and protein stability, reducing overall AR expression.

Conclusions:

  • p42/p44 MAPK pathway inhibition is a viable strategy to reduce AR activity in prostate cancer.
  • Targeting p42/p44 MAPK can inhibit AR function through gene-selective mechanisms.
  • Reducing p42/p44 MAPK activity offers a dual approach to combat prostate cancer by lowering AR expression and function.

More Related Videos

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...